The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iwasaki, H.
Right arrow Articles by Niho, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iwasaki, H.
Right arrow Articles by Niho, Y.
The Journal of Immunology, 1999, 163: 6907-6911.
Copyright © 1999 by The American Association of Immunologists

Production of Soluble Granulocyte Colony-Stimulating Factor Receptors from Myelomonocytic Cells1

Hiromi Iwasaki2,*, Kazuya Shimoda*, Seiichi Okamura*, Teruhisa Otsuka*, Koji Nagafuji*, Naoki Harada*, Yuju Ohno*, Toshihiro Miyamoto*, Koichi Akashi3,*, Mine Harada{dagger} and Yoshiyuki Niho*

* First Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan; and {dagger} Second Department of Internal Medicine, Okayama University School of Medicine, Okayama, Japan

It has been speculated that a soluble form of G-CSFR might be physiologically present in humans, since G-CSFR mRNA that lacks a transmembrane domain has been identified from a human myelomonocytic cell line. Here, we demonstrate human soluble G-CSFR (sG-CSFR) of two different molecular sizes (80 and 85 kDa) on an immunoblot analysis using Abs generated against the amino-terminal, extracellular domain of the full-length G-CSFR. Both isoforms of sG-CSFR were able to bind recombinant human G-CSF (rhG-CSF). RT-PCR analysis with primers targeted outside of the transmenbrane region revealed that membrane-anchored G-CSFR is expressed at all maturation stages of purified myeloid cells, including CD34+CD13+ cells (blasts), CD11b-CD15+ cells (promyelocytes or myelocytes), CD11b+CD15+ cells (metamyelocytes and mature neutrophils), and CD14+ cells (monocytes). On the other hand, sG-CSFR mRNA was detectable in CD11b-CD15+, CD11b+CD15+, and CD14+ cells, but not in the CD34+CD13+ blast population. The serum concentration of both isoforms of sG-CSFR appeared to be correlated with the numbers of neutrophils/monocytes before and after rhG-CSF treatment in normal individuals. Thus, two isoforms of sG-CSFR are physiologically secreted from relatively mature myeloid cells and might play an important role in myelopoiesis through their binding to serum G-CSF.




This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
M. Fukuda, M. Oka, Y. Ishida, H. Kinoshita, K. Terashi, M. Fukuda, S. Kawabata, A. Kinoshita, H. Soda, and S. Kohno
Effects of Renal Function on Pharmacokinetics of Recombinant Human Granulocyte Colony-Stimulating Factor in Lung Cancer Patients
Antimicrob. Agents Chemother., July 1, 2001; 45(7): 1947 - 1951.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.